Qualcomm’s AI Gamble: From Smartphones to Server Racks
featured
Technology

Qualcomm’s AI Gamble: From Smartphones to Server Racks

•
3 Min
By: QMoat
Deckers’ Q3: Tariff Jitters Create a Buying Window Amid Hoka’s Strong Moat
featured
Consumer Quality Leaders

Deckers’ Q3: Tariff Jitters Create a Buying Window Amid Hoka’s Strong Moat

•
3 Min
By: QMoat
Intel's Q3: A Fragile Comeback Gains Momentum
featured
Quick Takes Technology

Intel's Q3: A Fragile Comeback Gains Momentum

•
3 Min
By: QMoat

Latest

Zoetis Stumbles—But the Market May Be Overreacting

•
5 Min
A cute Dog

Giredestrant: Roche’s New Breast-Cancer Pill Fuels Big Dreams

•
6 Min
Giredestrant: Roche’s New Breast-Cancer Pill Fuels Big Dreams
featured

Qualcomm’s AI Gamble: From Smartphones to Server Racks

•
3 Min
Qualcomm’s AI Gamble: From Smartphones to Server Racks
featured

Deckers’ Q3: Tariff Jitters Create a Buying Window Amid Hoka’s Strong Moat

•
3 Min
Deckers’ Q3: Tariff Jitters Create a Buying Window Amid Hoka’s Strong Moat
featured

Europe’s Bake-Off Market Cools on Price, Heats Up on Competition

•
3 Min
Europe’s Bake-Off Market Cools on Price, Heats Up on Competition

Intel's Q3: A Fragile Comeback Gains Momentum

•
3 Min
Intel's Q3: A Fragile Comeback Gains Momentum
featured
Giredestrant: Roche’s New Breast-Cancer Pill Fuels Big Dreams
featured
Healthcare

Giredestrant: Roche’s New Breast-Cancer Pill Fuels Big Dreams

If giredestrant can secure a broad label and embed itself in treatment guidelines as a preferred endocrine partner, it would reinforce Roche’s franchise in breast cancer and create a recurring revenue stream with unusually high duration

•
6 Min
By: QMoat

Sign up for QMoat newsletters.

Stay up to date with curated collection of our top stories.

Please check your inbox and confirm. Something went wrong. Please try again.

Quality Leaders

Read all in Quality Leaders
Deckers’ Q3: Tariff Jitters Create a Buying Window Amid Hoka’s Strong Moat
featured
Consumer Quality Leaders

Deckers’ Q3: Tariff Jitters Create a Buying Window Amid Hoka’s Strong Moat

Deckers Outdoor’s stock stumbled despite solid Q3 results and resilient Hoka growth. With tariffs clouding guidance but free cash flow strong, the selloff looks overdone. At this valuation, the post-earnings drop offers long-term investors a rare entry point.

•
3 Min
By: QMoat
The 5 Top Quality Investors You’ve (Probably) Never Heard Of
Quality Leaders Investor Academy

The 5 Top Quality Investors You’ve (Probably) Never Heard Of

Most investors can name Buffett or Terry Smith. But a quieter elite of “quality purists” has been compounding capital far from the spotlight — from Montréal to Hong Kong, from Zurich to London. They buy great businesses, hold them for years, and let time do the heavy lifting.

•
3 Min
By: QMoat
Diamonds
featured
Quality Leaders

Why Quality Is Underperforming - And What Will Turn The Tide

After years of dominance, the quality factor has stumbled since mid-2024 as markets chased risk and valuations stretched. Narrow leadership and speculative fervor left steady earners behind—but shifting tides could soon restore quality’s quiet strength.

•
3 Min
By: QMoat
EPAM Bets on Itself With a $1 Billion Buyback—Its Entire Cash Pile
featured
Conviction Ideas Technology Quality Leaders

EPAM Bets on Itself With a $1 Billion Buyback—Its Entire Cash Pile

EPAM Systems unveiled a $1 billion share repurchase—roughly equal to its entire cash reserve. The bold move signals management’s conviction that the market undervalues the digital-engineering specialist’s long-term prospects.

•
2 Min
By: QMoat

Sector Deep Dives

Read all in Sector Deep Dives
Algorithms at the Drawbridge: Here's Why AI Is Widening the Brokers’ Moat
Finacials Sector Deep Dives

Algorithms at the Drawbridge: Here's Why AI Is Widening the Brokers’ Moat

For Marsh, Aon, WTW and Gallagher, AI looks less like a guillotine than a lever—stripping costs from placements, sharpening advisory clout, and spawning new insurable risks—even as it pressures small-ticket business. The winners weld data, governance and speed into advantage.

•
3 Min
By: QMoat
Diagnostics Lab
Healthcare Sector Deep Dives

Inside Diagnostics: The Five Players with the widest moat

Behind the quiet hum of hospital labs lies one of healthcare’s toughest moats. Roche, Abbott, and Danaher have built diagnostics empires so entrenched that rivals can’t pry them loose—analyzers, reagents, and data all locking customers in for decades.

•
5 Min
By: QMoat
Stockholm, Sweden
featured
Sector Deep Dives

The Nordic Engine: How Sweden Keeps Building Global Giants from a Small Corner of the Map

From IKEA to Spotify, Sweden keeps turning its modest size into a factory of world-class firms. The secret lies in long-term ownership, digital infrastructure, and a culture where ambition, trust, and design discipline quietly compound into global scale.

•
5 Min
By: QMoat
Payday’s Hidden Giants: Why U.S. Payroll Processors Keep Their Edge in a Crowded Market
featured
Sector Deep Dives

Payday’s Hidden Giants: Why U.S. Payroll Processors Keep Their Edge in a Crowded Market

Moving money from employers to employees may seem simple, but in payroll, complexity is the moat. From ADP’s dominance to Paychex’s bold Paycor deal, the sector’s leaders thrive on compliance expertise, sticky customer relationships, and the financial cushion of client-fund float.

•
6 Min
By: QMoat

Top categories

Investor Academy

37 posts

Technology

28 posts

Quality Leaders

26 posts

Sector Deep Dives

19 posts

Conviction Ideas

Read all in Conviction Ideas
EPAM Bets on Itself With a $1 Billion Buyback—Its Entire Cash Pile
featured
Conviction Ideas Technology Quality Leaders

EPAM Bets on Itself With a $1 Billion Buyback—Its Entire Cash Pile

EPAM Systems unveiled a $1 billion share repurchase—roughly equal to its entire cash reserve. The bold move signals management’s conviction that the market undervalues the digital-engineering specialist’s long-term prospects.

•
2 Min
By: QMoat
EPAM Systems and the AI Crossroads: How a Quiet Engineering Powerhouse Is Reinventing Its Moat
featured
Technology Conviction Ideas

EPAM Systems and the AI Crossroads: How a Quiet Engineering Powerhouse Is Reinventing Its Moat

EPAM Systems built its reputation by solving the hard tech problems others avoided. Now, as generative AI reshapes software services, the company faces its defining test: can its engineering-first DNA turn AI disruption into a new era of growth and competitive advantage?

•
5 Min
By: QMoat
Our Conviction Idea in September 2025: Marsh McLennan (MMC)
featured
Conviction Ideas Finacials

Our Conviction Idea in September 2025: Marsh McLennan (MMC)

Marsh McLennan’s stock is down, but secular growth drivers remain. Can the risk-adviser giant still deliver for long-term investors?

•
6 Min
By: QMoat
A female eye
Conviction Ideas

August 2025: Buy the Dip in Alcon (ALC)

Alcon's Q2 reporting was a slight miss. This does not mean that the structural story is broken. We buy the dip.

•
4 Min
By: QMoat

Investor Academy

Read all in Investor Academy
The 5 Top Quality Investors You’ve (Probably) Never Heard Of
Quality Leaders Investor Academy

The 5 Top Quality Investors You’ve (Probably) Never Heard Of

Most investors can name Buffett or Terry Smith. But a quieter elite of “quality purists” has been compounding capital far from the spotlight — from Montréal to Hong Kong, from Zurich to London. They buy great businesses, hold them for years, and let time do the heavy lifting.

•
3 Min
By: QMoat
Excess Cash: Why a Dollar on the Balance Sheet Isn’t Always Worth a Dollar
Investor Academy

Excess Cash: Why a Dollar on the Balance Sheet Isn’t Always Worth a Dollar

Cash may look simple, but valuing it rarely is. A dollar on the balance sheet can trade at a premium—or a discount—depending on how management is likely to use it. Academic research shows that the worth of “excess” cash hinges less on accounting than on trust.

•
3 Min
By: QMoat
How to Measure Corporate Culture
Investor Academy

How to Measure Corporate Culture

Corporate culture is notoriously hard to measure, yet it may be the single most important driver of long-term corporate success.

•
4 Min
By: QMoat
Shares of the Trenton Electric Water Company
featured
Investor Academy

Dual Share Classes: Good or Bad?

Dual-class share structures have become the favorite shield of modern founders—and the headache of modern investors. By separating control from ownership, they let visionaries steer without interference but also weaken accountability as companies mature.

•
4 Min
By: QMoat

Technology

Read all in Technology
Qualcomm’s AI Gamble: From Smartphones to Server Racks
featured
Technology

Qualcomm’s AI Gamble: From Smartphones to Server Racks

Qualcomm is stepping out of its mobile comfort zone with a bold push into AI infrastructure. Its new inference-focused datacenter chips aim to challenge Nvidia and AMD with lower power draw and cost-efficient performance.

•
3 Min
By: QMoat
Intel's Q3: A Fragile Comeback Gains Momentum
featured
Quick Takes Technology

Intel's Q3: A Fragile Comeback Gains Momentum

Intel’s third quarter showed a company slowly regaining its footing. Revenue ticked up, margins improved, and its foundry ambitions took shape—yet persistent losses and execution risks remind investors that this comeback, while real, remains fragile.

•
3 Min
By: QMoat
Lam’s September Quarter: Record Margins, AI Tailwinds—and a China Comedown in 2026
Technology Quick Takes

Lam’s September Quarter: Record Margins, AI Tailwinds—and a China Comedown in 2026

Lam Research delivered record margins on AI-fueled demand while warning China will fade under new curbs. Guidance dips on tariffs and mix, but 2026 growth bets rest on HBM, taller NAND stacks and EUV patterning—where Lam’s etch/deposition moat is deepest.

•
3 Min
By: QMoat
EPAM Bets on Itself With a $1 Billion Buyback—Its Entire Cash Pile
featured
Conviction Ideas Technology Quality Leaders

EPAM Bets on Itself With a $1 Billion Buyback—Its Entire Cash Pile

EPAM Systems unveiled a $1 billion share repurchase—roughly equal to its entire cash reserve. The bold move signals management’s conviction that the market undervalues the digital-engineering specialist’s long-term prospects.

•
2 Min
By: QMoat

Healthcare

Read all in Healthcare
A cute Dog
Healthcare

Zoetis Stumbles—But the Market May Be Overreacting

Zoetis shares plunged after a rare growth wobble in its pet-health franchise. But with margins intact and valuations reset, the selloff looks more like the end of a perfection trade than a structural break—raising the question: is this the moment to buy?

•
5 Min
By: QMoat
Giredestrant: Roche’s New Breast-Cancer Pill Fuels Big Dreams
featured
Healthcare

Giredestrant: Roche’s New Breast-Cancer Pill Fuels Big Dreams

If giredestrant can secure a broad label and embed itself in treatment guidelines as a preferred endocrine partner, it would reinforce Roche’s franchise in breast cancer and create a recurring revenue stream with unusually high duration

•
6 Min
By: QMoat
Novo's Wegovy
featured
Quick Takes Healthcare

What’s Going On at Novo Nordisk’s Board?

Novo Nordisk faces rare boardroom turmoil as its controlling foundation pushes for a sweeping overhaul. Chair Helge Lund and six directors are set to be replaced by a new slate led by ex-CEO Lars Rebien Sørensen—signaling a sharper, U.S.-focused pivot in the obesity-drug race.

•
3 Min
By: QMoat
Diagnostics Lab
Healthcare Sector Deep Dives

Inside Diagnostics: The Five Players with the widest moat

Behind the quiet hum of hospital labs lies one of healthcare’s toughest moats. Roche, Abbott, and Danaher have built diagnostics empires so entrenched that rivals can’t pry them loose—analyzers, reagents, and data all locking customers in for decades.

•
5 Min
By: QMoat

Industrials

Read all in Industrials
A Grasshopper
Quality Leaders Industrials

Rollins (ROL): A Recurring-Revenue Engine, One Home at a Time

Rollins has turned pest control into a dependable, subscription-like cash machine—growing organically, tucking in bolt-on deals and keeping churn low. With a seasoned bench, dense routes and disciplined pricing, the company keeps margins steady even as rivals regroup.

•
4 Min
By: QMoat
Industrial Gases
Industrials Quality Leaders

Linde (LIN) - A Quiet Giant With a Contractual Engine

Linde quietly dominates industrial gases with dense networks, proprietary engineering and long-term take-or-pay contracts that pass through energy costs, keeping cash flows steady.

•
4 Min
By: QMoat
SIG Combibloc (SIGN)—How the M&A Adventure Ended
Industrials

SIG Combibloc (SIGN)—How the M&A Adventure Ended

SIG’s shopping spree—Scholle IPN and Evergreen—blurred its aseptic razor-blade edge, lifted leverage, and squeezed margins. The reset hands Ola Rollén a clear brief: prune the commodity pieces, migrate what’s upgradeable to aseptic economics, and rebuild the core duopoly story.

•
3 Min
By: QMoat
A construction site at dawn
featured
Industrials

Amrize (AMRZ): A New Heavyweight Hiding in Plain Sight

Amrize, Holcim’s U.S. spin-off, pairs irreplaceable quarries with premium roofing—and trades at a discount to peers. A long-term buy.

•
5 Min
By: QMoat

Consumer

Read all in Consumer
Deckers’ Q3: Tariff Jitters Create a Buying Window Amid Hoka’s Strong Moat
featured
Consumer Quality Leaders

Deckers’ Q3: Tariff Jitters Create a Buying Window Amid Hoka’s Strong Moat

Deckers Outdoor’s stock stumbled despite solid Q3 results and resilient Hoka growth. With tariffs clouding guidance but free cash flow strong, the selloff looks overdone. At this valuation, the post-earnings drop offers long-term investors a rare entry point.

•
3 Min
By: QMoat
Europe’s Bake-Off Market Cools on Price, Heats Up on Competition
Consumer

Europe’s Bake-Off Market Cools on Price, Heats Up on Competition

After years of inflation-fueled price hikes, Europe’s bake-off industry faces tighter margins and fiercer retailer negotiations. With input costs easing, growth now depends on volume, mix, and efficiency rather than pricing power.

•
3 Min
By: QMoat
EssilorLuxottica’s Q3: How AI Will Deepend the Moat
featured
Quick Takes Consumer

EssilorLuxottica’s Q3: How AI Will Deepend the Moat

EssilorLuxottica’s best quarter since the merger shows momentum is real. Smart glasses, premium lenses, and a thriving retail engine turned Q3 into a breakthrough—suggesting the eyewear giant’s tech-infused growth story is just getting started.

•
3 Min
By: QMoat
Nescafe Cup
Quick Takes Consumer

Nestlé’s 9M 2025: Tough medicine, clearer diagnosis

Nestlé’s new CEO is taking tough action: 16,000 job cuts, sharper portfolio focus, and a push for RIG-led growth—real demand, not just pricing. After years of inflation-driven gains, the world’s biggest food group is betting on leaner operations and genuine volume recovery.

•
3 Min
By: QMoat

Sign up for QMoat newsletters.

Stay up to date with curated collection of our top stories.

Please check your inbox and confirm. Something went wrong. Please try again.